Trial record 1 of 1 for:    GSK Anti-IL5 MHE 104317 Mepolizumab
Previous Study | Return to List | Next Study

Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by GlaxoSmithKline
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00244686
First received: October 25, 2005
Last updated: March 19, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)